OPTIVA FERTILITY, INC.
MALDEN, MA · Founded 2020 · CIK 0001908871 · Medtech · Defunct
Fluorescence Lifetime Imaging (FLIM) metabolic imaging system with AI-based embryo viability assessment for IVF
- Grants
- $258K
- 1 award
- Sector median: 1
- Raised
- $3.0M
- 1 Form D · Feb 2022
- 56 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · AI-enhanced metabolic imaging: a non-invasive and precise IVF assessment tool | $257,945 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 935 | Medical Care Technologies Inc. | — | $50K |
| 936 | Endoshape, Inc. | — | $23M |
| 937 | Active Recovery TMS, LLC | — | $1.0M |
| 938 | OPTIVA FERTILITY, INC. | — | $3.0M |
| 939 | Prior Knowledge, Inc. | — | $2.0M |
| 940 | METFORA LLC | — | — |
| 941 | PeriCor LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Timothy SanchezDirector · Executive Officer
- Jonathan ThonDirector
- Deepak VermaDirector
Patents
- Artificial Intelligence Methods For Predicting Embryo Viability Based On Microscopy Methodsapplication
- Artificial Intelligence Methods For Predicting Embryo Viability Based On Microscopy Methodsapplication
- Fluorescence Lifetime Imaging Microscope Systems, And Methods Of Operating The Sameapplication
- Artificial Intelligence Methods For Predicting Embryo Viability Based On Microscopy Methodsapplication
- Fluorescence Lifetime Imaging Microscope Systems, And Methods Of Operating The Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.